Home » FIND

FIND

Aug 30, 2017

Study Highlights Cepheid's Next-Generation TB, Rifampicin Resistance Assay

Premium

The study is the first to demonstrate the design features and operational characteristics of Cepheid's Xpert MTB/RIF Ultra assay.

Dec 03, 2015

Cepheid, FIND to Evaluate Point-of-Care MDx System, TB Test

The partners are broadening their collaboration to bring point-of-care TB diagnostics to all levels of the health system in low- and middle-income countries.

Oct 08, 2015

Consortium Seeks to Provide Centralized Access to Global TB Data for Research, Dx Development

Premium

The database of genotype, phenotype, and clinical data from multi-drug resistant TB cases may support improved diagnostic development and clinical decision making.

Oct 07, 2015

Paul G. Allen Ebola Program Awards $6.9M for Ebola Diagnostics

Grants awarded to Chembio, BD, and FIND will help fund new diagnostic tests for Ebola and other fever-inducing illnesses and feasibility studies to evaluate them.

Jul 01, 2015

Field Evaluation of Rapid Ebola Immunoassay Reveals Limitations of PCR-Based Testing

Premium

A new study has found that an antigen-based rapid diagnostic test for Ebola could be more reliable under certain circumstances than a recently approved RT-PCR assay for the virus.

Apr 16, 2015

Cepheid Qualitative HIV-1 Test Receives CE Mark

The new cartridge-based test runs on the firm's GeneXpert platform and provides a 90-minute molecular diagnosis of HIV in high-risk individuals and infants.

Mar 19, 2015

Study IDs TB Strains in Swaziland with Drug Resistance Mutations Not Detected by Cepheid Xpert Test

Premium

Cepheid is now considering adapting TB tests in development to cover the mutations, an executive told GenomeWeb.

Dec 29, 2014

Cepheid's HIV MDx Assay Gains CE-IVD Mark

Shipping of the assay, Cepheid's eighth product release in 2014, is anticipated to begin in February 2015.

Oct 28, 2014

FIND Collaborates with Multiple Firms on MDx Tests for TB

NEW YORK (GenomeWeb) – The Foundation for Innovative New Diagnostics is collaborating with multiple firms to accelerate the development of low-cost molecular diagnostics for tuberculosis and drug resistance determination, the non-profit organization said today.

May 23, 2013

Studies Indicate Effectiveness of New LAMP-based Malaria Test in Modern Labs, Endemic Countries

Premium

A pair of recently published peer-reviewed studies has vetted the performance of a new test based on loop-mediated isothermal amplification, or LAMP, as a tool for the quick and easy diagnosis of malaria in both modernized laboratories and in the field in areas of the world where

Pages

The Scan

DNA Testing for Reunification Raises Ethics Issues

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

To Make Sure

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

Database of Trees

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

This Week in PLOS

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.